>>Pfizer's $14B Medivation deal's now a cautionary M&A tale, thanks to ASCO
I'm fairly sure if PFE had run the same trial as JNJ they would have shown even better results. I haven't kept track of what Xtandi trials they are in fact running.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.